Description
DRUG - CAPRELSA
First action · last action
2013-05-14 · 2013-05-20
Transactions
2
First transaction's obligation
$7,335
Base + all options value (sum of deltas)
$7,335
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0432
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-05-14+$7,335= $7,335
- Mod P000012013-05-20+$0= $7,335
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-05-14 | +$7,335 | $7,335 | DRUG - CAPRELSA |
| Mod P00001· CHANGE ORDER | 2013-05-20 | +$0 | $7,335 | DRUG - CAPRELSA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FBWCB39K5929)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA24117F0409 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $62,720 | FY2017 |
| VA24916J2992 | 596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS | $9,360 | FY2016 |
| VA24816F1925 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $7,567 | FY2016 |
| VA24916J2473 | 626-NASHVILLE (00626) · 6505 · DRUGS AND BIOLOGICALS | $10,442 | FY2016 |
| VA24916J2234 | 596-LEXINGTON(00596) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2016 |
| VA24816F1550 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $7,567 | FY2016 |
Other recipients under 6505 from 460-WILMINGTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24413J4050 | IMMUCOR INC | 460-WILMINGTON | $38,726 | FY2013 |
| VA24413J2944 | GRIFOLS BIOLOGICALS LLC | 460-WILMINGTON | $4,849 | FY2013 |
| VA24413P0204 | MCKESSON PLASMA AND BIOLOGICS LLC | 460-WILMINGTON | $20,507 | FY2013 |
| VA24412F1860 | SANOFI VACCINES US INC. | 460-WILMINGTON | $6,109 | FY2012 |
| VA24412F1826 | SANOFI VACCINES US INC. | 460-WILMINGTON | $57,645 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24413J2946_3600_VA797BP0432_3600 · retrieved 2026-09-26.